vs

Side-by-side financial comparison of Albemarle Corporation (ALB) and DILLARD'S, INC. (DDS). Click either name above to swap in a different company.

DILLARD'S, INC. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.0× Albemarle Corporation). Albemarle Corporation runs the higher net margin — 22.3% vs 8.8%, a 13.5% gap on every dollar of revenue. On growth, Albemarle Corporation posted the faster year-over-year revenue change (32.7% vs 2.9%). Albemarle Corporation produced more free cash flow last quarter ($247.6M vs $156.2M). Over the past eight quarters, Albemarle Corporation's revenue compounded faster (-0.1% CAGR vs -16.9%).

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

ALB vs DDS — Head-to-Head

Bigger by revenue
DDS
DDS
1.0× larger
DDS
$1.5B
$1.4B
ALB
Growing faster (revenue YoY)
ALB
ALB
+29.7% gap
ALB
32.7%
2.9%
DDS
Higher net margin
ALB
ALB
13.5% more per $
ALB
22.3%
8.8%
DDS
More free cash flow
ALB
ALB
$91.4M more FCF
ALB
$247.6M
$156.2M
DDS
Faster 2-yr revenue CAGR
ALB
ALB
Annualised
ALB
-0.1%
-16.9%
DDS

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
ALB
ALB
DDS
DDS
Revenue
$1.4B
$1.5B
Net Profit
$319.1M
$129.8M
Gross Margin
35.1%
43.4%
Operating Margin
16.3%
11.5%
Net Margin
22.3%
8.8%
Revenue YoY
32.7%
2.9%
Net Profit YoY
671.7%
4.2%
EPS (diluted)
$2.34
$8.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALB
ALB
DDS
DDS
Q1 26
$1.4B
Q4 25
$1.4B
$1.5B
Q3 25
$1.3B
$1.5B
Q2 25
$1.3B
$1.5B
Q1 25
$1.1B
$2.0B
Q4 24
$1.2B
$1.4B
Q3 24
$1.4B
$1.5B
Q2 24
$1.4B
$1.5B
Net Profit
ALB
ALB
DDS
DDS
Q1 26
$319.1M
Q4 25
$-414.2M
$129.8M
Q3 25
$-160.7M
$72.8M
Q2 25
$22.9M
$163.8M
Q1 25
$41.3M
$214.4M
Q4 24
$75.3M
$124.6M
Q3 24
$-1.1B
$74.5M
Q2 24
$-188.2M
$180.0M
Gross Margin
ALB
ALB
DDS
DDS
Q1 26
35.1%
Q4 25
13.9%
43.4%
Q3 25
9.0%
36.6%
Q2 25
14.8%
43.9%
Q1 25
14.5%
34.9%
Q4 24
11.2%
42.6%
Q3 24
-7.7%
37.6%
Q2 24
-0.7%
44.6%
Operating Margin
ALB
ALB
DDS
DDS
Q1 26
16.3%
Q4 25
-15.2%
11.5%
Q3 25
-16.6%
6.2%
Q2 25
3.6%
14.0%
Q1 25
1.8%
11.7%
Q4 24
0.4%
11.4%
Q3 24
-81.9%
6.5%
Q2 24
-34.4%
15.2%
Net Margin
ALB
ALB
DDS
DDS
Q1 26
22.3%
Q4 25
-29.0%
8.8%
Q3 25
-12.3%
4.8%
Q2 25
1.7%
10.7%
Q1 25
3.8%
10.6%
Q4 24
6.1%
8.7%
Q3 24
-78.9%
5.0%
Q2 24
-13.2%
11.6%
EPS (diluted)
ALB
ALB
DDS
DDS
Q1 26
$2.34
Q4 25
$-3.88
$8.31
Q3 25
$-1.72
$4.66
Q2 25
$-0.16
$10.39
Q1 25
$0.00
$13.41
Q4 24
$0.29
$7.73
Q3 24
$-9.45
$4.59
Q2 24
$-1.96
$11.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALB
ALB
DDS
DDS
Cash + ST InvestmentsLiquidity on hand
$1.1B
$1.1B
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$10.1B
$2.0B
Total Assets
$15.1B
$4.3B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALB
ALB
DDS
DDS
Q1 26
$1.1B
Q4 25
$1.1B
Q3 25
$1.9B
$1.0B
Q2 25
$1.8B
$900.5M
Q1 25
$1.5B
$717.9M
Q4 24
$1.2B
$980.4M
Q3 24
$1.7B
$946.7M
Q2 24
$1.8B
$817.8M
Total Debt
ALB
ALB
DDS
DDS
Q1 26
$1.9B
Q4 25
$3.2B
Q3 25
$3.6B
Q2 25
$3.6B
Q1 25
$3.5B
Q4 24
$3.5B
Q3 24
$3.6B
Q2 24
$3.5B
Stockholders' Equity
ALB
ALB
DDS
DDS
Q1 26
$10.1B
Q4 25
$9.5B
$2.0B
Q3 25
$10.0B
$1.9B
Q2 25
$10.2B
$1.9B
Q1 25
$10.0B
$1.8B
Q4 24
$10.0B
$2.0B
Q3 24
$10.2B
$1.9B
Q2 24
$11.2B
$1.9B
Total Assets
ALB
ALB
DDS
DDS
Q1 26
$15.1B
Q4 25
$16.4B
$4.3B
Q3 25
$17.1B
$3.7B
Q2 25
$17.3B
$3.9B
Q1 25
$17.0B
$3.5B
Q4 24
$16.6B
$4.1B
Q3 24
$17.5B
$3.7B
Q2 24
$18.4B
$3.9B
Debt / Equity
ALB
ALB
DDS
DDS
Q1 26
0.19×
Q4 25
0.33×
Q3 25
0.36×
Q2 25
0.35×
Q1 25
0.35×
Q4 24
0.35×
Q3 24
0.35×
Q2 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALB
ALB
DDS
DDS
Operating Cash FlowLast quarter
$346.2M
$186.5M
Free Cash FlowOCF − Capex
$247.6M
$156.2M
FCF MarginFCF / Revenue
17.3%
10.6%
Capex IntensityCapex / Revenue
6.9%
2.1%
Cash ConversionOCF / Net Profit
1.09×
1.44×
TTM Free Cash FlowTrailing 4 quarters
$577.3M
$781.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALB
ALB
DDS
DDS
Q1 26
$346.2M
Q4 25
$388.5M
$186.5M
Q3 25
$355.6M
$86.8M
Q2 25
$-7.2M
$232.6M
Q1 25
$545.4M
$364.7M
Q4 24
$674.0K
$173.5M
Q3 24
$240.5M
$-68.4M
Q2 24
$362.9M
$244.4M
Free Cash Flow
ALB
ALB
DDS
DDS
Q1 26
$247.6M
Q4 25
$233.1M
$156.2M
Q3 25
$223.4M
$60.1M
Q2 25
$-126.8M
$215.8M
Q1 25
$362.8M
$349.3M
Q4 24
$-355.1M
$145.4M
Q3 24
$-62.6M
$-94.3M
Q2 24
$-84.7M
$209.2M
FCF Margin
ALB
ALB
DDS
DDS
Q1 26
17.3%
Q4 25
16.3%
10.6%
Q3 25
17.1%
4.0%
Q2 25
-9.5%
14.1%
Q1 25
33.7%
17.3%
Q4 24
-28.8%
10.2%
Q3 24
-4.6%
-6.3%
Q2 24
-5.9%
13.5%
Capex Intensity
ALB
ALB
DDS
DDS
Q1 26
6.9%
Q4 25
10.9%
2.1%
Q3 25
10.1%
1.8%
Q2 25
9.0%
1.1%
Q1 25
17.0%
0.8%
Q4 24
28.9%
2.0%
Q3 24
22.4%
1.7%
Q2 24
31.3%
2.3%
Cash Conversion
ALB
ALB
DDS
DDS
Q1 26
1.09×
Q4 25
1.44×
Q3 25
1.19×
Q2 25
-0.31×
1.42×
Q1 25
13.19×
1.70×
Q4 24
0.01×
1.39×
Q3 24
-0.92×
Q2 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons